Trade TNYA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Tenaya Therapeutics, Inc. (TNYA) is trading at US$0.68, up 0.40% today as of Sep 21, 13:52 EDT. The company has a market capitalisation of US$156.36M. Over the past 52 weeks, TNYA has traded between US$0.53 and US$2.35. On Syfe you can trade TNYA with $0 commission and add it to your watchlist.
| Previous close | US$0.68 |
|---|---|
| Market cap | US$156.36M |
| 52-week range | US$0.53 – US$2.35 |
| Volume | 4.87M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Tenaya Therapeutics, Inc.
Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. Its programs include TN-201, TN-401, and TN-301. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Newell Olson in 2016 and is headquartered in South San Francisco, CA.
Year: 2021
Tenaya Therapeutics Names Eric Hyllengren CFO
Jun 29, 1:09 PM · MT Newswires
Tenaya Therapeutics, Inc. (TNYA) stock is trading at US$0.68, +0.40% from the previous close of US$0.68.
The market cap for Tenaya Therapeutics, Inc. (TNYA) stock is approximately US$156.36M.
The 52-week high for Tenaya Therapeutics, Inc. (TNYA) stock is US$2.35.
The 52-week low for Tenaya Therapeutics, Inc. (TNYA) stock is US$0.53.
Tenaya Therapeutics, Inc. (TNYA) does not currently pay a dividend.
Stay on top of TNYA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
